A Study of the Safety and Effectiveness of CNTO 148 (Golimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (CR014188)
This study has been terminated.
(protocol was cancelled, company decision)
Sponsor:
Centocor, Inc.
Collaborator:
Schering-Plough
Information provided by:
Centocor, Inc.
ClinicalTrials.gov Identifier:
NCT00488774
First received: June 18, 2007
Last updated: August 16, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | May 2009 |
| Primary Completion Date: | May 2009 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | December 3, 2009 |